Status:
COMPLETED
CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.
Lead Sponsor:
AstraZeneca
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice
Eligibility Criteria
Inclusion
- Patients in secondary prevention of cardiopathy (ischaemic heart disease, claudication intermittence, thrombotic apoplexy cerebri, diabetes) who are not followed in an outpatient department.
Exclusion
- Patients who suffer from diabetic nephropathy will be excluded
- According to the general practitioners appraisal, patients who suffer from severe co morbidity can be excluded as well.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
2193 Patients enrolled
Trial Details
Trial ID
NCT00713960
Start Date
April 1 2008
End Date
December 1 2010
Last Update
January 16 2012
Active Locations (66)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Albertslund, Denmark
2
Research Site
Arhus C, Denmark
3
Research site
Assens, Denmark
4
Research Site
Billund, Denmark